Cellectis S.A. (EPA:ALCLS)
4.120
-0.120 (-2.83%)
At close: Dec 5, 2025
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
€321,270
Profits / Employee
€137,586
Market Cap
297.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
Cellectis News
- 2 days ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 17 days ago - Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells - GlobeNewsWire
- 23 days ago - Cellectis Q3 2025 Earnings Preview - Seeking Alpha
- 4 weeks ago - Cellectis (CLLS) Reports Strong Q3 Revenue Growth and Promising Clinical Data - GuruFocus
- 4 weeks ago - Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M - Seeking Alpha
- 4 weeks ago - Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Cellectis Earnings Preview - Benzinga
- 4 weeks ago - Cellectis (CLLS) to Present Key Research at 2025 ASH Meeting - GuruFocus